Novo Nordisk A/S
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters The roughly $1,000 monthly price tag of Eli Lilly‘s weight loss drug Zepbound put the blockbuster treatment out of reach for Willow Baillies, 29, whose insurance does not cover it. Baillies, […]
Read More
European markets open higher in shortened session ahead of Christmas
European markets opened higher on Tuesday, in a shortened trading session for Christmas Eve. Stocks in Europe ended Monday’s session slightly higher, as investors reacted to more disappointing economic news out of the U.K., and the pan-European Stoxx 600 was lifted by a recovery in the share price of pharmaceuticals giant Novo Nordisk. There is […]
Read More
The ‘weight-loss trade’ has stalled. What it will take to revive investor interest
Anyone who’s been on a diet can likely relate: Those first lost pounds are met with a sense of euphoria. The voice inside one’s head screams: “I’ve got this!” But then, it inevitably becomes a slog. The initial novelty wears off, and the real work begins. Investors may see a parallel to the initial elation […]
Read More
Eli Lilly looks to extend its winning streak over the broader market to 6 years
Eli Lilly has outperformed the S & P 500 for five straight years as Wall Street woke up to its massive opportunity in obesity drugs. Six in a row is not out of the question. Year-to-date performance: Up 33.7% Forward price-to-earnings ratio: 34.3 versus five-year average of 34.5 Our rating: Buy-equivalent 1 Our price target: […]
Read More
Stocks making the biggest moves midday: Nordstrom, Honda, MicroStrategy, Broadcom and more
Check out the companies making headlines in midday trading: Nordstrom — The department store shares dipped more than 1% after announcing it will become a private company. Nordstrom agreed to a buyout deal valued at roughly $6.25 billion from its founding family and Mexican department store El Puerto de Liverpool. Common shareholders will receive $24.25 […]
Read More
Stocks making the biggest moves premarket: Novo Nordisk, Honda, Xerox, Tesla and more
Check out the companies making headlines in premarket trading. Novo Nordisk — The stock jumped about 5%, rebounding from the nearly 18% losses seen in the previous session. On Friday, the Danish pharmaceutical giant’s experimental weight loss drug, CagriSema, reported late-stage trial results that missed expectations . Honda – U.S.-listed shares surged 15% after the […]
Read More
CNBC Daily Open: Inflation and dot plots
A person shops at a Whole Foods Market grocery store on December 17, 2024 in New York City. Spencer Platt | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Like […]
Read More
CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?
A customer, holding a carton of eggs at a supermarket, in United States on Dec. 20, 2024. Secuk Ancar | Anadolu | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. […]
Read More
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. Shelby Knowles | Bloomberg | Getty Images The Food and Drug Administration approved Eli Lilly‘s blockbuster weight loss drug Zepbound for treating patients with the most common sleep-related breathing disorder, the drugmaker announced […]
Read More
Stocks making the biggest moves midday: Novo Nordisk, Mission Produce, Occidental Petroleum and more
Check out the companies making headlines in midday trading: JPMorgan , Bank of America , Wells Fargo — The three U.S. banks that dominate transactions on the Zelle payments network all rose around 2% despite a Friday lawsuit from the Consumer Financial Protection Bureau over Zelle payment fraud. Crypto-linked stocks — Shares of MicroStrategy , […]
Read More